Delivery Order SPE2DB20D3103-SPE2DB24FM7S0

Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,914.52, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The delivery order has a firm fixed-price pricing type and an ultimate completion date of February 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,849.62 firm fixed-price contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The contract has a ceiling value of $9,492.10 and a completion date of March 27, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,716.72 firm-fixed-price contract is for the supply of Sandostatin LAR Depot 20 mg kits, a specialty medication. The award has an ultimate completion date of December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,955.42, is for the supply of Sandostatin LAR Depot 10 mg kits, a specialty medication. The contract has an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The $17,709.77 firm fixed-price delivery order, which is not set aside, has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,642.67, is for the supply of Sandostatin LAR Depot 20 mg kits, a specialty pharmaceutical medication. The contract has a period of performance through March 14, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $35,107.52 firm fixed-price contract is for the supply of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $24,124.54 and is for the delivery of Sandostatin LAR Depot 20 mg pharmaceutical kits. The contract has a period of performance through March 7, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Sandostatin LAR Depot 20 mg kits. The contract is a firm-fixed-price delivery order with a ceiling value of $3,229.10 and an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM7S0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The $3,914.52 firm fixed-price contract has a period of performance through February 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 12:28 PM